Загрузка...
Upregulation of Peroxiredoxin-2 in Well-Differentiated Pancreatic Neuroendocrine Tumors and Its Utility as a Biomarker for Predicting the Response to Everolimus
Pancreatic neuroendocrine neoplasms (pNENs) account for 2–3% of pancreatic malignancies. Peroxiredoxins (Prdxs), which are major cellular antioxidants, are involved in multiple oncogenic signaling pathways. We investigated the role of peroxiredoxin-2 in QGP-1 human pNEN cell line and patient-derived...
Сохранить в:
| Опубликовано в: : | Antioxidants (Basel) |
|---|---|
| Главные авторы: | , , , , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
MDPI
2020
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7696978/ https://ncbi.nlm.nih.gov/pubmed/33182509 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/antiox9111104 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|